RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNXT RenovoRx Inc

盘前交易 08-20 08:57:11 EDT

1.32

+0.15

+12.39%

盘前1.30

-0.01-1.08%

08:46 EDT

最高1.34	最低1.15	成交量58.23万
今开1.17	昨收1.17	日振幅16.00%
总市值5,924万	流通市值5,151万	总股本4,505万
成交额73.63万	换手率1.49%	流通股本3,917万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.315,"timestamp":1787169600000,"preClose":1.17,"halted":0,"volume":582344,"hourTrading":{"tag":"盘前","latestPrice":1.3008,"preClose":1.315,"latestTime":"08:46 EDT","volume":5675,"amount":7421.847287500001,"timestamp":1787229987940,"change":-0.0142,"changeRate":-0.010798,"amplitude":0.068289},"delay":0,"changeRate":0.12393162393162395,"floatShares":39171100,"shares":45052700,"eps":-0.309615,"marketStatus":"盘前交易","change":0.145,"latestTime":"08-20 08:57:11 EDT","open":1.17,"high":1.3372,"low":1.15,"amount":736267.6519856,"amplitude":0.16,"askPrice":1.35,"askSize":15000,"bidPrice":1.19,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.309615,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787232600000},"marketStatusCode":1,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.315,"preHourTrading":{"tag":"盘前","latestPrice":1.3008,"preClose":1.315,"latestTime":"08:46 EDT","volume":5675,"amount":7421.847287500001,"timestamp":1787229987940,"change":-0.0142,"changeRate":-0.010798,"amplitude":0.068289},"postHourTrading":{"tag":"盘后","latestPrice":1.2613,"preClose":1.315,"latestTime":"19:59 EDT","volume":14117,"amount":18376.9424,"timestamp":1787183956421,"change":-0.0537,"changeRate":-0.040837,"amplitude":0.050494},"volumeRatio":0.6933153637511859},"requestUrl":"/m/hq/s/RNXT","defaultTab":"news","newsList":[{"id":"1103143027","title":"RenovoRx公布2026年第二季度创纪录业绩：商业应用加速推动，季度营收环比增长61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103143027","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103143027?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:06","pubTimestamp":1786565203,"startTime":"0","endTime":"0","summary":"RenovoRx Inc（股票代码：RNXT）近日发布2026年第二季度财报，交出了一份亮眼的成绩单。公司不仅实现了创纪录的季度营收，更展现出强劲的增长势头——这一成绩的背后，是商业应用范围的持续扩大与市场接纳度的显著提升。具体来看，公司第二季度营收较上一季度激增61%，这无疑为投资者注入了一剂强心针。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187526150","title":"RenovoRx宣布FDA授予孤儿药资格认定：奥沙利铂用于胰腺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1187526150","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187526150?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:34","pubTimestamp":1779971685,"startTime":"0","endTime":"0","summary":"RenovoRx公司近日宣布，其用于治疗胰腺癌的药物奥沙利铂已获得美国食品药品监督管理局（FDA）授予的孤儿药资格认定。这一认定标志着该药物在针对罕见病治疗领域取得了重要进展，有望为胰腺癌患者带来新的治疗选择。孤儿药资格认定通常能为药物研发公司提供一定的市场独占期、税收抵免以及临床试验费用补助等优惠政策，从而加速创新疗法的开发与上市进程。此次认定不仅体现了监管机构对该药物潜力的认可，也可能为RenovoRx的未来发展注入新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013871","title":"Renovorx, Inc.盘中异动 快速跳水6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514013871?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:43","pubTimestamp":1740494624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时43分，Renovorx, Inc.股票出现波动，股价快速下挫6.99%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224345a2538a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224345a2538a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775835","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.07%报0.978美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514775835?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:49","pubTimestamp":1740412145,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时49分，Renovorx, Inc.股票出现异动，股价急速跳水5.07%。截至发稿，该股报0.978美元/股，成交量5.7118万股，换手率0.16%，振幅5.82%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234905abdb2057&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234905abdb2057&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512963631","title":"Renovorx, Inc.盘中异动 下午盘快速拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512963631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512963631?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:02","pubTimestamp":1739905374,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时02分，Renovorx, Inc.股票出现波动，股价急速拉升5.77%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190302549627c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190302549627c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511690892","title":"Renovorx, Inc.盘中异动 临近午盘急速拉升5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511690892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511690892?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:32","pubTimestamp":1739550751,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时32分，Renovorx, Inc.股票出现波动，股价急速拉升5.83%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150032329885a625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150032329885a625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511352524","title":"Renovorx, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511352524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511352524?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:36","pubTimestamp":1739460977,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时36分，Renovorx, Inc.股票出现异动，股价快速下挫5.17%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233617a244b97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233617a244b97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510805053","title":"Renovorx, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510805053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510805053?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:46","pubTimestamp":1739285204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时46分，Renovorx, Inc.股票出现异动，股价急速下挫5.22%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224644a241fe53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224644a241fe53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865313","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510865313?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分，Renovorx, Inc.股票出现异动，股价急速下挫5.17%。截至发稿，该股报1.10美元/股，成交量1.4272万股，换手率0.06%，振幅4.25%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223554abc9a68d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223554abc9a68d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744760","title":"Renovorx, Inc.股价重挫12.33% 市值跌378.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744760?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:30","pubTimestamp":1738938622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时30分，Renovorx, Inc.股票出现异动，股价急速下跌12.33%。截至发稿，该股报1.28美元/股，成交量9.2024万股，换手率0.38%，振幅0.00%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223023abc62a58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223023abc62a58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505869596","title":"Renovorx, Inc.盘中异动 大幅上涨7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505869596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505869596?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:31","pubTimestamp":1737729076,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时31分，Renovorx, Inc.股票出现异动，股价快速拉升7.97%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223116abb74e2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223116abb74e2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505104664","title":"Renovorx, Inc.盘中异动 临近午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505104664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505104664?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:51","pubTimestamp":1737651107,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时51分，Renovorx, Inc.股票出现异动，股价快速下挫5.07%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124005147960e5f7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124005147960e5f7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505203882","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.33%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505203882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505203882?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:51","pubTimestamp":1737474693,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时51分，Renovorx, Inc.股票出现波动，股价大幅拉升5.33%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为1.73%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121235133a22a690e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121235133a22a690e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503918313","title":"Renovorx, Inc.盘中异动 股价大涨6.38%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503918313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503918313?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:33","pubTimestamp":1737037985,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时33分，Renovorx, Inc.股票出现异动，股价大幅拉升6.38%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622330598688be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622330598688be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503515585","title":"Renovorx, Inc.盘中异动 大幅下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503515585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503515585?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:37","pubTimestamp":1736779026,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时37分，Renovorx, Inc.股票出现异动，股价大幅下挫5.26%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132237069864d6d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132237069864d6d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502889855","title":"Renovorx, Inc.盘中异动 股价大涨6.06%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502889855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502889855?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:31","pubTimestamp":1736519465,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时31分，Renovorx, Inc.股票出现异动，股价大幅拉升6.06%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223105aba60229&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223105aba60229&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501774664","title":"Renovorx, Inc.盘中异动 股价大涨5.10%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501774664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501774664?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:52","pubTimestamp":1736347932,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时52分，Renovorx, Inc.股票出现异动，股价快速上涨5.10%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225212aba350b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225212aba350b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500972269","title":"Renovorx, Inc.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500972269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500972269?lang=zh_cn&edition=full","pubTime":"2025-01-03 01:31","pubTimestamp":1735839087,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日01时31分，Renovorx, Inc.股票出现异动，股价急速拉升5.81%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501030131279859228c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501030131279859228c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500558612","title":"Renovorx, Inc.盘中异动 股价大涨5.76%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500558612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500558612?lang=zh_cn&edition=full","pubTime":"2025-01-01 00:11","pubTimestamp":1735661481,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日00时11分，Renovorx, Inc.股票出现异动，股价大幅拉升5.76%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101001122a2109f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101001122a2109f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495505146","title":"Renovorx, Inc.盘中异动 临近收盘大幅拉升5.00%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495505146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495505146?lang=zh_cn&edition=full","pubTime":"2024-12-31 04:52","pubTimestamp":1735591977,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日04时52分，Renovorx, Inc.股票出现异动，股价急速上涨5.00%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231045257a20f7adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231045257a20f7adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com;renovorx.com","stockEarnings":[{"period":"1week","weight":0.1741},{"period":"1month","weight":0.5225},{"period":"3month","weight":0.4916},{"period":"6month","weight":0.4406},{"period":"1year","weight":0.4272},{"period":"ytd","weight":0.5653}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RenovoRx, Inc.于2012年12月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，为高度未满足的医疗需求开发专有的靶向联合疗法，目标是改善接受治疗的癌症患者的治疗结果。该公司专有的经动脉微灌注（TAMPT）治疗平台旨在确保精确的治疗递送，以直接针对肿瘤，同时潜在地最大限度地降低治疗相对于全身（静脉注射（称为“IV”）治疗）的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.049533},{"month":2,"riseRate":0.6,"avgChangeRate":0.102207},{"month":3,"riseRate":0.2,"avgChangeRate":-0.093103},{"month":4,"riseRate":0,"avgChangeRate":-0.163527},{"month":5,"riseRate":0.6,"avgChangeRate":0.050959},{"month":6,"riseRate":0.6,"avgChangeRate":0.043263},{"month":7,"riseRate":0.2,"avgChangeRate":-0.031811},{"month":8,"riseRate":0.4,"avgChangeRate":-0.021087},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050074},{"month":10,"riseRate":0,"avgChangeRate":-0.120676},{"month":11,"riseRate":0.6,"avgChangeRate":0.028303},{"month":12,"riseRate":0.6,"avgChangeRate":0.479671}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}